Yongan Pharmaceutical: decreased revenue but increased net profit in H1 2016

Summary: On 3 Nov., 2016, Yongan Pharmaceutical released an announcement to further explain its financial performance in H1 2016. Its ethylene oxide business was seen declined revenue due to oversupply, depressed price and reduced production. On the ...

Amino Acids China E-News 201611

www.cnchemicals.com